Meeting FDA and GMP Compliance Standards for Nutraceutical Dissolvable Strips

1. Introduction

I’ve been working in thin-film nutraceutical manufacturing and regulatory compliance for close to a decade. Started on the production floor, spent years in quality assurance, and for the last several years I’ve been helping brand owners and contract manufacturers navigate the compliance requirements that determine whether a dissolvable vitamin strip can legally be sold in the U.S. market.

And I can tell you this: the difference between a manufacturer that’s genuinely compliant and one that just claims to be is usually visible in the documentation — or the lack of it.

FDA doesn’t require pre-market approval for dietary supplement strips. That’s a fact that sometimes creates a false sense of security. Just because you don’t need FDA approval to launch a product doesn’t mean you can skip the manufacturing requirements. Under 21 CFR Part 111, every facility that manufactures, packages, labels, or holds dietary supplements must comply with Current Good Manufacturing Practice regulations. The FDA has issued warning letters to dietary supplement manufacturers for significant CGMP violations as recently as December 2025, and enforcement activity is increasing.

The global oral thin films market reached USD 4.04 billion in 2024 and is projected to grow to USD 8.91 billion by 2032. The nutraceutical segment — dissolvable vitamin strips, energy strips, sleep strips — is a significant part of that growth. Retailers are demanding documented quality systems. Amazon now requires third-party cGMP verification for every dietary supplement sold on its U.S. marketplace. And consumers are increasingly scanning labels for certification marks.

This guide breaks down what FDA and GMP compliance actually requires for nutraceutical dissolvable strips — the regulations, the certifications, the documentation, the testing, and the verification steps that separate a compliant manufacturer from one that’s hoping you won’t ask too many questions.

2. The Regulatory Framework: What FDA Actually Requires

21 CFR Part 111 is the regulation that governs dietary supplement manufacturing. It applies to anyone who manufactures, packages, labels, or holds dietary supplements — including those who import dietary supplements into the United States.

The regulation imposes extensive requirements across multiple areas. It covers personnel qualifications and training. It covers the physical plant and grounds — design, construction, sanitation. It covers equipment and utensils. And it covers the quality control system: recordkeeping, documentation, planning, control, and improvement processes.

For dissolvable strips specifically, there are a few areas where Part 111 requirements are particularly demanding.

Production and process controls. The regulation requires a system of production and process controls covering all stages of manufacturing, packaging, labeling, and holding. For strips, this means documented control over the film-forming solution preparation, the coating and drying parameters, the slitting and cutting operations, and the packaging process. Each of these stages has critical parameters that affect product quality, and each has to be monitored and recorded.

Recordkeeping. The FDA’s June 2026 notice to OMB focused specifically on recordkeeping requirements. The proposed collection relates to records showing what is being manufactured, whether controls ensure the product’s identity, purity, strength, and composition, whether contaminant limits are effective, and whether deviations occurred with appropriate corrective action.

The recordkeeping requirements establish written procedures and records for personnel, sanitation, calibration of instruments and controls, equipment maintenance and cleaning, water used in production, production and process controls, quality control, components and packaging, master manufacturing and batch production records, laboratory operations, manufacturing operations, packaging and labeling operations, holding and distribution, returned products, and product complaints.

That’s a comprehensive list. And the records aren’t just for the manufacturer — they have to be available for FDA inspection.

Supplier qualification. FDA regulations require qualifying ingredient suppliers and verifying the information provided on Certificates of Analysis before relying on them. For strips, this means qualifying the suppliers of film-forming polymers, plasticizers, active ingredients, flavoring agents, and packaging materials. Each supplier has to be documented as qualified, and the COA information has to be verified.

3. NSF/ANSI 455-2: The Certification That Opens Doors

NSF/ANSI 455-2 is the Good Manufacturing Practices standard developed specifically for dietary supplement facilities. It’s the certification that retailers, distributors, and B2B partners increasingly require before signing supply agreements.

The standard was developed through consensus among industry representatives, public health officials, regulators, and consumer interest groups. It encompasses FDA 21 CFR Part 111 requirements while incorporating retailer quality expectations and industry best practices that exceed baseline regulatory mandates. The 2024 version includes references to 21 CFR Part 111, 21 CFR Part 117, and 21 CFR Part 11 — the latter covering electronic records and signatures.

Here’s what the certification actually involves. Facilities must maintain strict documentation protocols, implement comprehensive quality controls, and submit to regular unannounced audits. NSF auditors examine everything from employee training records to floor sanitation procedures to finished goods testing protocols. The certification remains active only through continuous compliance, with annual audits verifying that facilities maintain the same standards required for initial certification.

In September 2025, Korean ODF manufacturer CL Pharm obtained NSF/ANSI 455-2 certification for its Oral Dissolving Films category. The company’s manufacturing system for film-type formulations passed independent review against the international standard. Multiple global retailers and B2B partners require this certification as a precondition for doing business, and obtaining it strengthened the company’s credibility and access in ODF-focused export and co-development projects.

For a brand owner sourcing dissolvable vitamin strips, NSF/ANSI 455-2 certification is the single most important third-party verification to look for. It means the facility has been independently audited against a standard that exceeds the FDA baseline, and it means the certification is maintained through ongoing surveillance rather than a one-time inspection.

4. Documentation and Recordkeeping: The Compliance Backbone

If I had to identify the single most common gap between compliant and non-compliant manufacturers, it would be documentation. FDA compliance is ultimately a documentation exercise. You can have the best manufacturing process in the world, but if it isn’t documented and traceable, it doesn’t count.

Master Manufacturing Records (MMRs). Every product requires an MMR that specifies the formulation, the manufacturing process, the equipment, the in-process controls, and the acceptance criteria. The MMR is the master document from which batch production records are generated.

Batch Production Records (BPRs). Every production batch generates a BPR that records what actually happened during manufacturing. The BPR must document that the batch was produced according to the MMR, including any deviations and their investigation.

Laboratory records. All testing performed on raw materials, in-process samples, and finished products must be documented. This includes test methods, results, acceptance criteria, and the qualifications of the analyst or laboratory.

Equipment qualification. IQ/OQ/PQ protocols for critical equipment — the coating line, the drying system, the slitting and cutting machinery, the packaging equipment — demonstrate that the equipment is properly installed, operates correctly, and performs consistently. Calibration certificates for all instrumentation are also required.

21 CFR Part 11 compliance. The electronic records and signatures rule applies to any computerized system used in the manufacturing or quality process. The system must have audit trails, access controls, and data integrity protections. Manufacturers using paper-based systems need documented controls for version control and signature verification.

For a brand owner evaluating a manufacturer, the documentation system is something you can — and should — audit. Request sample MMRs and BPRs (with proprietary information redacted as needed). Ask to see the equipment qualification records. Request the validation master plan. A manufacturer that has these documents readily available is one that operates with a real quality system.

5. Quality Control Testing: Specifications That Matter

The quality control testing program determines whether the product meets its specifications. For dissolvable vitamin strips, the critical specifications fall into several categories.

Content uniformity. This is the most demanding specification. Each strip must contain the labeled dose within the acceptance criteria. The USP standard specifies that content should be between 85% and 115% of label claim, with a standard deviation of less than 6%. The testing is performed on individual strips, not on a composite sample. A composite test would mask the strip-to-strip variation that content uniformity is designed to detect.

Dissolution and disintegration. For oral thin films, USP <2048> provides the dissolution testing framework. The FDA and USP guidelines recommend a disintegration time of 30 seconds or less for fast-dissolving oral films. Testing is performed using standard basket or paddle apparatus.

Moisture content. The residual moisture in the finished film should be below 5%. Above that, the film becomes sticky and difficult to handle, and excess moisture can accelerate degradation of sensitive vitamins.

Microbial limits. Because the film contacts the oral mucosa directly, microbial limits are stringent. Total aerobic count, yeast and mold, and absence of specified pathogens are standard release specifications.

Seal integrity. For the primary packaging — typically aluminum sachets — seal integrity testing is essential. Peel strength, dye penetration, and vacuum decay testing verify that each sachet is properly sealed and will maintain the moisture barrier through shipping and storage.

Stability. Both accelerated and long-term stability studies are required to establish shelf life. Accelerated conditions (40°C/75% RH) provide an early indication of degradation pathways. Long-term studies at standard conditions (25°C/60% RH) confirm the actual shelf life.

6. Manufacturing Environment: Why Cleanrooms Are Non-Negotiable

Dissolvable strips are thin, have high surface area relative to their mass, and are moisture-sensitive. These characteristics make them particularly vulnerable to contamination and environmental variation.

ODF production lines require specific environmental controls: temperature regulation between 18–25°C, humidity control between 40–60% RH, and cleanroom classifications typically ISO Class 7 or 8. The cleanroom classification means controlled particle counts, HEPA filtration, and positive pressure to prevent ingress of unfiltered air.

GMP compliance in ODF production requires ISO Class 7/8 cleanroom integration, HEPA filtration, and positive pressure to prevent microbial contamination and maintain product stability. The environmental controls aren’t optional — they’re a technical necessity for a product that dissolves rapidly on the tongue and has a short residence time in the package before it reaches the consumer.

The environmental monitoring program also matters. A compliant facility monitors particle counts, temperature, humidity, and microbial levels on a defined schedule, with alert and action limits documented. Trending data is reviewed regularly, and deviations are investigated. This isn’t just about passing an audit — it’s about detecting environmental drift before it affects product quality.

7. Supply Chain Compliance: Ingredients, Packaging, and Traceability

A dissolvable vitamin strip is only as compliant as its weakest input. FDA regulations require that ingredient suppliers be qualified and their COAs verified.

Active ingredients. For vitamins, the supplier must provide a COA showing identity, purity, potency, and conformance to specification. For botanical extracts and novel ingredients, additional documentation may be required, including identification testing and contaminant screening. The identity of every incoming batch must be verified — either through testing or through a documented supplier qualification program that meets FDA’s requirements.

Film-forming polymers. The HPMC, pullulan, and other polymers used in the film matrix are food-grade or pharmaceutical-grade excipients. They must have documented specifications and be sourced from qualified suppliers with quality agreements in place.

Packaging materials. The primary package — typically an aluminum foil laminate sachet — must be food-contact compliant and provide the required moisture and oxygen barrier. The supplier of the packaging material must be qualified, and the packaging must be tested for seal integrity and barrier performance.

Traceability. Finished product must be traceable back to the raw material lots used in production. A batch of strips that fails a stability test six months after release needs to be traceable to the specific ingredient lots and packaging materials used. This is a regulatory requirement and a practical risk management tool.

8. Real-World Case: Esther Formula’s U.S. Facility Build

Let me share a case that illustrates what it actually takes to bring a dissolvable strip operation into compliance for the U.S. market.

The Background: Esther Formula USA, a subsidiary of a South Korean health and beauty products maker, wanted to bring its Bio360 line of thin, quickly dissolving nutritional supplement strips to the U.S. market. The company had been successful in Asia and needed a U.S.-based manufacturing facility that met FDA and cGMP standards.

The Build: The company acquired a 67,243-square-foot former cannabis manufacturing plant near Lampson Field Airport in Lakeport, California, and transformed it into a production center specializing in thin, quickly dissolving strips.

The build wasn’t a cosmetic renovation. According to CFO YooJung Kim, the company “rebuilt the inside from the ground up, spending about a year and a half on construction to meet FDA, cGMP, state and county standards”.

The facility produces glutathione, CBD, and ceramide strips, with three additional products — saffron, collagen, and melatonin — in research and development. Sales scaled rapidly, from six to fourteen cartons daily in June to as many as 200 a day within months, driven by influencer marketing and consumer interest on platforms like TikTok and Amazon.

What This Case Illustrates: The year-and-a-half construction timeline tells you something about the scope of what’s required. Meeting FDA and cGMP standards for a dissolvable strip facility isn’t a matter of buying the right equipment and plugging it in. It’s a facility design project that requires controlled environments, validated processes, documented quality systems, and the infrastructure to support all of it.

The case also illustrates the market opportunity. Esther Formula moved from a former cannabis facility to a high-volume ODF production center because there was demand for the product format. But the compliance investment came first — the facility had to meet the standards before the products could be sold.

For brand owners evaluating a manufacturer, this case is a reminder that compliance capability is a capital investment. A manufacturer that has made that investment is one that can support long-term brand growth. One that hasn’t is one that will hit a wall when a retailer asks for the cGMP certificate.

9. The Amazon Effect: Third-Party cGMP Verification

In January 2026, Amazon implemented a policy change that affects every dietary supplement sold on its U.S. marketplace: all sellers must demonstrate cGMP compliance verified by an Amazon-approved third-party Testing, Inspection, and Certification (TIC) provider.

The policy requires that all products be manufactured in a facility with a valid, non-expired third-party cGMP certification under 21 CFR 111 or 21 CFR 117. Sellers typically have 90 days to submit the required documentation after their ASIN is flagged as a dietary supplement.

The accepted cGMP programs include NSF/ANSI 455-2 and equivalent certifications from accredited bodies. The verification is performed by an Amazon-approved TIC organization, and the certification must be current.

What this means for brand owners: If you’re planning to sell dissolvable vitamin strips on Amazon — and for many brands, that’s a primary channel — the manufacturer you choose must hold a valid cGMP certification from an accredited third-party certifier. This isn’t a “nice to have” anymore. It’s a marketplace access requirement.

The policy also creates a verification burden. The certification documentation has to be obtained from the manufacturer and submitted through Amazon’s system. If the manufacturer’s certification has lapsed, or if it was issued by a body that isn’t on Amazon’s approved list, the product can’t be listed. This makes the certification status of your manufacturing partner a supply chain risk factor that needs to be monitored, not just verified once at the start of the relationship.

10. What to Verify When Auditing a Dissolvable Strip Manufacturer

Based on years of evaluating thin-film manufacturers for compliance, here’s the framework I use when assessing whether a potential partner can actually meet FDA and GMP requirements.

Certification verification. Request the current NSF/ANSI 455-2 certificate (or equivalent from an accredited body). Verify the certificate is active by checking the certifying body’s online database. Confirm that the certification scope covers Oral Dissolving Films — a general dietary supplement certification may not cover the specific manufacturing processes used for thin films.

Regulatory registration. Verify that the facility is registered with FDA as a dietary supplement manufacturer. This is a baseline requirement. An unregistered facility is not operating legally.

Documentation system review. Request sample MMRs and BPRs (with proprietary information appropriately redacted). Ask to see the equipment qualification records — IQ/OQ/PQ protocols and reports. Request the validation master plan. A manufacturer with a real quality system will have these documents organized and readily available.

Environmental monitoring data. Request the cleanroom classification certificate and the environmental monitoring records. The facility should be ISO Class 7 or 8 with documented particle count, temperature, humidity, and microbial monitoring. Trending data should be available for review.

Quality control testing records. Request content uniformity test results from recent production batches. The data should show individual strip assay results, not just composite averages. Look for RSD values below 6% and individual results within 85–115% of label claim.

Supply chain qualification. Ask for the supplier qualification records for critical raw materials — the film-forming polymers, active ingredients, and packaging materials. The manufacturer should be able to demonstrate that each supplier has been qualified and that COA information has been verified.

Recall and complaint history. Ask about any product recalls, FDA warning letters, or significant consumer complaints. A manufacturer that has had compliance issues and can demonstrate corrective action is different from one that has had issues and hasn’t addressed them. But a clean record is always the preference.

Certification of the audit. If possible, conduct an on-site audit or request a recent third-party audit report. NSF/ANSI 455-2 certification already involves regular unannounced audits, but a brand owner’s own audit provides additional assurance specific to their product and quality requirements.

11. Common Questions About FDA and GMP Compliance

Q: Do dissolvable vitamin strips need FDA approval before they can be sold?

No. Dissolvable vitamin strips are regulated as dietary supplements under DSHEA, not as drugs. They don’t require pre-market approval. However, they must be manufactured in compliance with 21 CFR Part 111 cGMP regulations, and the facility must be registered with FDA.

Q: What’s the difference between 21 CFR Part 111 and NSF/ANSI 455-2?

21 CFR Part 111 is the FDA regulation that establishes minimum cGMP requirements for dietary supplements. NSF/ANSI 455-2 is a voluntary certification standard developed by NSF International that encompasses the Part 111 requirements and adds retailer quality expectations and industry best practices. Certification to 455-2 demonstrates compliance with Part 111 and goes beyond it.

Q: How is content uniformity tested for dissolvable strips?

Content uniformity is tested by assaying individual strips — typically 10 units — using HPLC or UV spectroscopy. Each strip must fall within 85–115% of the labeled dose, and the relative standard deviation must not exceed 6%. Composite testing is not acceptable for content uniformity verification.

Q: What documentation does a dissolvable strip manufacturer need to maintain?

The manufacturer must maintain Master Manufacturing Records, Batch Production Records, laboratory testing records, equipment qualification records, calibration records, supplier qualification records, environmental monitoring records, complaint files, and records of any deviations and corrective actions. The records must be retained for at least one year past the shelf life of the product.

Q: How often is NSF/ANSI 455-2 certification renewed?

The certification is maintained through continuous compliance, with annual audits. NSF conducts regular unannounced audits to verify that facilities maintain the standards required for initial certification. The certification remains active as long as the facility passes these audits.

Q: What happens if a dissolvable strip manufacturer fails an FDA inspection?

FDA can issue a Form 483 listing inspectional observations, or a Warning Letter for more serious violations. If the violations are significant enough, FDA can take enforcement action including product seizure, injunction, or import alert. Products manufactured under conditions that don’t meet cGMP are considered adulterated under the Federal Food, Drug, and Cosmetic Act.

Q: Can a manufacturer sell dissolvable vitamin strips on Amazon without cGMP certification?

No. As of January 2026, Amazon requires all dietary supplement sellers on its U.S. marketplace to demonstrate cGMP compliance verified by an Amazon-approved third-party TIC provider. The product must be manufactured in a facility with a valid, non-expired third-party cGMP certification under 21 CFR 111 or 21 CFR 117.

12. Final Thoughts

FDA and GMP compliance for nutraceutical dissolvable strips isn’t a checkbox exercise. It’s a system — documentation, testing, environmental control, supply chain management — that has to be designed, implemented, and maintained.

Here’s what I’d tell any brand owner sourcing dissolvable vitamin strips:

Certification is the starting point, not the finish line. NSF/ANSI 455-2 certification tells you the facility passed an independent audit against a recognized standard. It doesn’t tell you whether the specific product you’re sourcing meets your quality requirements. Verify the certification, but also verify the product-specific quality data.

Content uniformity is the specification that matters most. It’s the hardest to achieve consistently and the easiest to fail during scale-up. Ask for individual strip test data, not composite results. Look for RSD below 6% across every batch.

Documentation is the evidence of compliance. A manufacturer with a real quality system has the MMRs, BPRs, equipment qualification records, and environmental monitoring data organized and available. One that doesn’t is one that’s hoping you won’t ask.

The Amazon requirement changes the sourcing calculus. If your sales channel includes Amazon, your manufacturer must hold a current cGMP certification from an approved third-party certifier. This is now a marketplace access requirement, not a voluntary quality signal.

Compliance is a capital investment. The Esther Formula case showed a year-and-a-half construction timeline to meet FDA and cGMP standards. Manufacturers that have made that investment can support long-term brand growth. Those that haven’t will hit a wall when the retailer asks for the certificate.

The oral thin films market is heading toward USD 8.91 billion by 2032, and the nutraceutical segment is a significant part of that growth. The brands that succeed in that market will be the ones whose manufacturing partners treat compliance as a system requirement — not just a certificate on a wall.